TURTLE PHARMA PRIVATE LTD
Overview
TURTLE PHARMA PRIVATE LTD is an active pharmaceutical ingredient (API) supplier with 6 active FDA Type II Drug Master Files, covering CIPROFLOXACIN HYDROCHLORIDE USP; CIPROFLOXACIN LACTATE; CIPROFLOXACIN USP; ENROFLOXACIN USP; LEVOFLOXACIN HEMIHYDRATE USP; OFLOXACIN USP.
Core services & business areas
Active pharmaceutical ingredients supplied
Substances TURTLE PHARMA PRIVATE LTD is evidenced to supply (US FDA Drug Master File or EU CEP). Open any ingredient to see its full supplier landscape, CAS number and patent status.
API / Drug Master Files
TURTLE PHARMA PRIVATE LTD holds 6 active (6 total) FDA Type II Drug Master Files — identifying it as an active-substance / API supplier. Type II DMFs are filed with the FDA to support the use of an active pharmaceutical ingredient in drug applications.
- LEVOFLOXACIN HEMIHYDRATE USPActive2018-10-16
- CIPROFLOXACIN HYDROCHLORIDE USPActive2018-10-16
- CIPROFLOXACIN LACTATEActive2018-10-16
- CIPROFLOXACIN USPActive2018-10-16
- ENROFLOXACIN USPActive2018-10-16
- OFLOXACIN USPActive2018-10-16
FDA compliance signals
No FDA recalls, Warning Letters, or Form 483 observations are linked to TURTLE PHARMA PRIVATE LTD in our records. PharmaTek screens the full directory against live FDA enforcement data.
Is this TURTLE PHARMA PRIVATE LTD? Get in front of buyers actively sourcing.
We route real sourcing requests from pharma buyers to vetted, verified partners — qualified leads, not just a listing. Tell us what you make and we'll be in touch about becoming a Verified Supplier Partner.
Ready to Accelerate Your
Discovery Workflow?
Find, vet, and source drug-manufacturing partners faster — with FDA compliance screening built in. Start free for 7 days.